BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeusset LM, McManus KJ. Characterizing and exploiting the many roles of aberrant H2B monoubiquitination in cancer pathogenesis. Semin Cancer Biol 2022;86:782-98. [PMID: 34953650 DOI: 10.1016/j.semcancer.2021.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Leng AM, Radmall KS, Shukla PK, Chandrasekharan MB. Quantitative Assessment of Histone H2B Monoubiquitination in Yeast Using Immunoblotting. Methods Protoc 2022;5. [PMID: 36287046 DOI: 10.3390/mps5050074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tan SYX, Zhang J, Tee WW. Epigenetic Regulation of Inflammatory Signaling and Inflammation-Induced Cancer. Front Cell Dev Biol 2022;10:931493. [PMID: 35757000 DOI: 10.3389/fcell.2022.931493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhou J, Xing Z, Xiao Y, Li M, Li X, Wang D, Dong Z. The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas. Front Mol Biosci 2022;9:816939. [DOI: 10.3389/fmolb.2022.816939] [Reference Citation Analysis]
4 Zheng L, He J, Li M, Yuan H, Li H, Hu F, Chen L, Tang W, Sheng M. Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153810] [Reference Citation Analysis]